v3.25.1
Schedule of Equity and Non-Controlling Interests (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Non-controlling companies net loss $ (6,587,362) $ (7,215,425)
Net loss non-controlling interest (14,431) (393,903)
Prior period balance (89,671)  
Ending period balance (104,102)  
Exozyme Technologies Inc [Member]    
Non-controlling companies net loss $ (44,789) $ (1,008,457)
Weighted average non-controlling percentage 32.22% 39.06%
Net loss non-controlling interest $ (14,431) $ (393,903)
Prior period balance (89,671) 7,250
Stock-based compensation 142,810
Ending period balance $ (104,102) $ (243,843)